Content area

|
|

Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer

Forfattere
Uffe Klausen1, Mads Hald Andersen1 & Lars Møller Pedersen2 1) Center for Cancer Immunterapi, Hæmatologisk Afdeling, Herlev og Gentofte Hospital 2) Hæmatologisk Afdeling, Herlev og Gentofte Hospital Ugeskr Læger 2017;179:V03170220
Reference: 
Ugeskr Læger 2017;179:V03170220
Blad nummer: 
Sidetal: 
2-6
Micro-environment being agonist as well as antagonist in B-cell non-Hodgkin lymphoma pathology
The tumour micro-environment has emerged as an essential component in B-cell non-Hodgkin lymphoma pathology, with both nurturing and protective cells. The diversity and impact of the micro-environment seems to be greater in the indolent lymphoma types, while the aggressive subtypes are more independent. The prognostic impact of the environmental cells seems to depend on the specific treatment, and novel treatments targeting the micro-environment are emerging. Immune checkpoints, expressed by lymphomas, serve as promising targets for immune checkpoint inhibitors and vaccination therapy.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Bente Bundgaard | 19/07
36 kommentarer
af Bente Lützen | 16/07
1 Kommentar
af Christian Frøkjær Thomsen | 16/07
1 Kommentar
af Klaus Roelsgaard | 15/07
2 kommentarer
af Geske Johanne Glahn | 14/07
1 Kommentar
af Finn Redke | 14/07
4 kommentarer
af Finn Redke | 14/07
3 kommentarer